NTRA insider transaction filings
Natera, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-18. Screen NTRA transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 40 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 132 legs across 31 filings by 9 insiders — 307,985 shares, $95,160,792 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: sale of 17,933 shares @ $327.97 ($5,881,529) by Rabinowitz Matthew, filed 2026-09-11.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Rabinowitz Matthew — EXECUTIVE CHAIRMAN, Director | 6 | — | 39 legs · 157,449 sh · $52,760,761 | — |
| RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER | 4 | — | 19 legs · 52,621 sh · $13,604,400 | — |
| Sheena Jonathan — Director | 7 | — | 35 legs · 29,538 sh · $9,456,895 | — |
| Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS | 5 | — | 16 legs · 26,784 sh · $8,211,241 | 1 |
| ROSENMAN HERM — Director | 2 | — | 1 leg · 16,530 sh · $4,132,500 | 2 |
| Chapman Steven Leonard — CEO AND PRESIDENT, Director | 3 | — | 10 legs · 10,544 sh · $2,844,519 | — |
| Fesko John — PRESIDENT, CHIEF BUS. OFFICER | 3 | — | 4 legs · 8,525 sh · $2,614,711 | 1 |
| Brophy Michael Burkes — CHIEF FINANCIAL OFFICER | 2 | — | 7 legs · 5,859 sh · $1,498,664 | — |
| Chapman Rowan E — Director | 2 | — | 1 leg · 135 sh · $37,101 | 2 |
| BOTHA ROELOF — Director | 1 | — | — | 2 |
+5 more insiders in the window, not shown — every filing appears in the table below.
Recent Form 4 filings — Natera, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-18 | 4 | Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS | Gift (G): 945 @ $0 | EDGAR |
| 2026-09-17 | 4 | Sheena Jonathan — Director | Sale (S): 6,000 @ $350.07 · Sale (S): 200 @ $348.02 · Sale (S): 100 @ $349.05 · Sale (S): 1,400 @ $353.83 · Sale (S): 450 @ $354.91 · Sale (S): 800 @ $355.95 · +1 more | EDGAR |
| 2026-09-16 | 4 | Rabinowitz Matthew — EXECUTIVE CHAIRMAN, Director | Sale (S): 1,537 @ $328.09 · Sale (S): 6,015 @ $329.12 · Sale (S): 6,206 @ $330.05 · Sale (S): 3,494 @ $330.98 · Sale (S): 1,000 @ $332.02 · Sale (S): 2,246 @ $333.07 · +23 more | EDGAR |
| 2026-09-11 | 4 | Rabinowitz Matthew — EXECUTIVE CHAIRMAN, Director | Sale (S): 800 @ $325.01 · Sale (S): 3,647 @ $326.11 · Sale (S): 10,556 @ $327.14 · Sale (S): 17,933 @ $327.97 · Sale (S): 15,764 @ $328.95 · Sale (S): 1,300 @ $329.62 | EDGAR |
| 2026-09-03 | 4 | Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS | Sale (S): 1,000 @ $319.76 · Sale (S): 1,400 @ $320.92 · Sale (S): 600 @ $321.91 · Sale (S): 15,160 @ $326.89 | EDGAR |
| 2026-09-03 | 4 | Chapman Steven Leonard — CEO AND PRESIDENT, Director | Sale (S): 1,698 @ $320.99 | EDGAR |
| 2026-08-28 | 4 | Fesko John — PRESIDENT, CHIEF BUS. OFFICER | Grant/award (A): 20,000 @ $0 · Sale (S): 6,517 @ $321.53 | EDGAR |
| 2026-08-14 | 4 | Sheena Jonathan — Director | Sale (S): 6,000 @ $325.32 | EDGAR |
| 2026-08-07 | 4 | Sheena Jonathan — Director | Sale (S): 100 @ $308.40 · Sale (S): 400 @ $310.23 · Sale (S): 400 @ $311.88 · Sale (S): 900 @ $313.07 · Sale (S): 850 @ $314.25 · Sale (S): 600 @ $315.32 · +4 more | EDGAR |
| 2026-08-07 | 4 | Rabinowitz Matthew — EXECUTIVE CHAIRMAN, Director | Sale (S): 2,000 @ $320.90 | EDGAR |
| 2026-08-05 | 4 | Sheena Jonathan — Director | Sale (S): 109 @ $267.99 | EDGAR |
| 2026-08-05 | 4 | Rabinowitz Matthew — EXECUTIVE CHAIRMAN, Director | Sale (S): 731 @ $267.99 | EDGAR |
| 2026-08-05 | 4 | RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER | Sale (S): 334 @ $267.99 | EDGAR |
| 2026-08-05 | 4 | Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS | Sale (S): 410 @ $267.99 · Sale (S): 300 @ $259.98 · Sale (S): 200 @ $261.49 · Sale (S): 947 @ $263.94 · Sale (S): 192 @ $265.27 · Sale (S): 1,233 @ $267.79 · +1 more | EDGAR |
| 2026-08-05 | 4 | Fesko John — PRESIDENT, CHIEF BUS. OFFICER | Sale (S): 295 @ $267.99 | EDGAR |
| 2026-08-05 | 4 | Chapman Steven Leonard — CEO AND PRESIDENT, Director | Sale (S): 1,182 @ $267.99 · Sale (S): 160 @ $259.98 · Sale (S): 70 @ $261.02 · Sale (S): 676 @ $263.86 · Sale (S): 80 @ $265.27 · Sale (S): 296 @ $267.08 · +1 more | EDGAR |
| 2026-08-05 | 4 | Brophy Michael Burkes — CHIEF FINANCIAL OFFICER | Sale (S): 317 @ $267.99 · Sale (S): 478 @ $274.22 | EDGAR |
| 2026-07-29 | 4 | Fesko John — PRESIDENT, CHIEF BUS. OFFICER | Sale (S): 782 @ $260.49 · Sale (S): 931 @ $254.07 | EDGAR |
| 2026-07-29 | 4 | RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER | Sale (S): 884 @ $260.49 · Sale (S): 1,003 @ $254.07 | EDGAR |
| 2026-07-29 | 4 | Rabinowitz Matthew — EXECUTIVE CHAIRMAN, Director | Sale (S): 1,718 @ $260.49 | EDGAR |
| 2026-07-29 | 4 | Sheena Jonathan — Director | Sale (S): 288 @ $260.49 · Sale (S): 191 @ $254.07 | EDGAR |
| 2026-07-29 | 4 | Brophy Michael Burkes — CHIEF FINANCIAL OFFICER | Sale (S): 782 @ $260.49 · Sale (S): 1,241 @ $254.07 · Sale (S): 1,008 @ $253.77 · Sale (S): 170 @ $254.33 · Sale (S): 1,863 @ $249.38 | EDGAR |
| 2026-07-29 | 4 | Chapman Steven Leonard — CEO AND PRESIDENT, Director | Sale (S): 2,190 @ $260.49 · Sale (S): 3,580 @ $254.07 | EDGAR |
| 2026-07-29 | 4 | Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS | Sale (S): 1,010 @ $260.49 · Sale (S): 1,204 @ $254.07 | EDGAR |
| 2026-07-17 | 4 | Chapman Rowan E — Director | Sale (S): 135 @ $274.82 | EDGAR |
| 2026-07-17 | 4 | Sheena Jonathan — Director | Sale (S): 450 @ $273.05 · Sale (S): 90 @ $274.26 · Sale (S): 170 @ $275.26 · Sale (S): 40 @ $276.38 · Sale (S): 390 @ $273.01 · Sale (S): 100 @ $273.68 · +2 more | EDGAR |
| 2026-07-15 | 4 | Sheena Jonathan — Director | Sale (S): 500 @ $262.72 · Sale (S): 800 @ $264.29 · Sale (S): 400 @ $265.15 · Sale (S): 500 @ $266.75 · Sale (S): 450 @ $267.72 · Sale (S): 500 @ $268.39 | EDGAR |
| 2026-07-08 | 4 | Rabinowitz Matthew — EXECUTIVE CHAIRMAN, Director | Sale (S): 1,000 @ $280 | EDGAR |
| 2026-07-06 | 4 | Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS | Sale (S): 100 @ $267.19 · Sale (S): 2,600 @ $272.99 · Sale (S): 300 @ $274.06 | EDGAR |
| 2026-07-06 | 4 | RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER | Sale (S): 1,568 @ $266.79 · Sale (S): 3,705 @ $268.11 · Sale (S): 1,932 @ $268.99 · Sale (S): 484 @ $269.87 · Sale (S): 1,357 @ $270.96 · Sale (S): 454 @ $272.14 · +6 more | EDGAR |
| 2026-06-30 | 4 | Rubin Eric H — Director | Grant/award (A): 75 | EDGAR |
| 2026-06-30 | 4 | Chapman Rowan E — Director | Grant/award (A): 1,571 · Grant/award (A): 103 | EDGAR |
| 2026-06-30 | 4 | Bertagnolli Monica — Director | Grant/award (A): 1,571 · Grant/award (A): 75 | EDGAR |
| 2026-06-30 | 4 | Marcus Gail Boxer — Director | Grant/award (A): 1,571 · Grant/award (A): 98 | EDGAR |
| 2026-06-30 | 4 | Baynes Roy D. — Director | Grant/award (A): 1,571 · Grant/award (A): 75 | EDGAR |
| 2026-06-30 | 4 | Lynch Thomas J. Jr. — Director | Grant/award (A): 1,905 | EDGAR |
| 2026-06-30 | 4 | ROSENMAN HERM — Director | Grant/award (A): 1,571 · Grant/award (A): 106 | EDGAR |
| 2026-06-30 | 4 | BOTHA ROELOF — Director | Grant/award (A): 1,571 · Grant/award (A): 120 | EDGAR |
| 2026-06-26 | 4 | RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER | Sale (S): 16,204 @ $250.25 · Sale (S): 1,200 @ $251.60 · Sale (S): 5,066 @ $252.31 · Sale (S): 11,130 @ $253.39 | EDGAR |
| 2026-06-26 | 4 | ROSENMAN HERM — Director | Sale (S): 16,530 @ $250 | EDGAR |
| 2026-06-22 | 4 | Sheena Jonathan — Director | Sale (S): 256 @ $218.14 · Sale (S): 128 @ $219.26 · Sale (S): 122 @ $220.93 · Sale (S): 244 @ $221.46 · Sale (S): 267 @ $218.18 · Sale (S): 96 @ $219.13 · +3 more | EDGAR |
| 2026-06-17 | 4 | Chapman Rowan E — Director | Sale (S): 2,964 @ $216.78 | EDGAR |
| 2026-06-17 | 4 | Sheena Jonathan — Director | Sale (S): 1,750 @ $210.29 · Sale (S): 600 @ $211.34 · Sale (S): 500 @ $212.42 · Sale (S): 300 @ $213.54 | EDGAR |
| 2026-06-16 | 4 | Rabinowitz Matthew — EXECUTIVE CHAIRMAN, Director | Sale (S): 2,536 @ $209.50 · Sale (S): 3,267 @ $210.30 · Sale (S): 2,957 @ $211.61 · Sale (S): 12,142 @ $212.27 · Sale (S): 5,034 @ $213.43 · Sale (S): 5,707 @ $214.35 · +15 more | EDGAR |
| 2026-06-09 | 4 | Marcus Gail Boxer — Director | Option exercise (M): 11,000 @ $22.83 · Sale (S): 3,016 @ $216.06 · Sale (S): 4,694 @ $217.30 · Sale (S): 3,174 @ $218.11 · Sale (S): 116 @ $218.81 · Option exercise (M): 11,000 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Chapman Steven Leonard — CEO AND PRESIDENT, Director | Sale (S): 832 @ $212.42 · Sale (S): 2,503 @ $213.44 · Sale (S): 1,300 @ $214.83 · Sale (S): 5,499 @ $216.13 · Sale (S): 2,351 @ $217.04 · Sale (S): 1,742 @ $218.28 · +8 more | EDGAR |
| 2026-06-03 | 4 | Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS | Sale (S): 1,802 @ $217.52 · Sale (S): 413 @ $218.84 · Sale (S): 213 @ $219.34 · Sale (S): 572 @ $220.67 | EDGAR |
| 2026-06-03 | 4 | Rubin Eric H — Director | Grant/award (A): 2,124 | EDGAR |
| 2026-06-03 | 4 | BOTHA ROELOF — Director | Sale (S): 26,411 @ $218.69 · Sale (S): 10,100 @ $219.78 · Sale (S): 21,304 @ $220.94 · Sale (S): 14,885 @ $221.58 · Sale (S): 2,850 @ $222.79 · Sale (S): 2,450 @ $223.83 | EDGAR |
| 2026-05-28 | 4 | Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS | Sale (S): 1,652 @ $202.84 | EDGAR |
Recent 8-K events — Natera, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-06 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-06-16 | 8-K/A | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-16 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-05 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-01 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-05 | 8-K | 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=NTRA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →